Skip to main content
Year archive

GC CELL CORPORATION — 2020 filings

All 22 regulatory filings released by GC CELL CORPORATION (144510) in 2020, sourced directly from the official regulator.

22 Filings
2020 Period
2020 filings (22)
Filing Released Lang
분기보고서 (2020.09)
Interim / Quarterly Report 9M 2020
2020-11-16 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q3 2020
2020-10-28 Korean
반기보고서 (2020.06)
Interim / Quarterly Report H1 2020
2020-08-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q2 2020
2020-07-28 Korean
기타경영사항(특허권취득)(자율공시)(신규한 약물 전달용 조성물 및 이를 유효성분으로 포함하는 GM1 강글리오사이드증 치료용 약학적 조성물)
Regulatory Filings
2020-07-21 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings
2020-07-01 Korean
타법인주식및출자증권취득결정
Share Issue/Capital Change
2020-06-25 Korean
기타경영사항(특허권취득)(자율공시)(T 세포를 이용한 자연살해세포의 배양방법)
Regulatory Filings
2020-06-18 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Q1 2020
2020-05-15 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q1 2020
2020-04-29 Korean
사업보고서 (2019.12)
Annual Report FY 2019
2020-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2020-03-24 Korean
감사보고서제출
Regulatory Filings
2020-03-16 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2020-03-06 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2020-03-06 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q4 2019
2020-02-06 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2020-02-06 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2020-02-06 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports
2020-02-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-01-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-01-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-01-02 Korean